Myeloma Crowd Radio: Veronika Bachanova, MD, PhD, University of Minnesota

Natural killer cells are the body's way of eliminating cancerous cells. When a myeloma patient's immune system is too weak, the natural killer cells can't effectively do their job to eliminate myeloma. A study is now being done to test donor natural killer cells in relapsed myeloma patients. The natural killer cells are collected and combined with IL-2 to help them grow and expand. Elotuzumab is used to help the NK cells migrate to the myeloma tumor and has anti-myeloma effect on its own. Learn more about this treatment that could help myeloma patients who are relapsed or refractory to standard myeloma therapies or help them bridge to other therapies like allogenic transplant or future CAR T studies.  

Thanks to our episode sponsor, Celgene Corporation.